Virtual West Oncology Conference


 

ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythropoiesis in LR-IR Disease? Is EFS Better With Pevonedistat+Aza vs. Aza Alone in HR-MDS? Should We Combine Ven+Aza?

118 views
March 11, 2021
0 Comments
Login to view comments. Click here to Login
Videos